TP53 and cancer: Based on this, a Mdm2-based cancer therapy can be achieved by two approaches: (1) Since Mdm2 mediated mono-ubiquitinylation of p53 is the key for p53 spatial trafficking and subsequent apoptosis initiation, inhibition of polyubiquitinylation of p53 can lead to an effective therapy.